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Abstract
Background: Nemaline myopathy is a neuromuscular disorder characterized by the presence of
nemaline bodies in patient muscles. 20% of the cases are associated with α-skeletal muscle actin
mutations. We previously showed that actin mutations can cause four different biochemical
phenotypes and that expression of NM associated actin mutants in fibroblasts, myoblasts and
myotubes induces a range of cellular defects.
Findings:  We conducted the same biochemical experiments for twelve new actin mutants
associated with nemaline myopathy. We observed folding and polymerization defects.
Immunostainings of these and eight other mutants in transfected cells revealed typical cellular
defects such as nemaline rods or aggregates, decreased incorporation in F-actin structures,
membrane blebbing, the formation of thickened actin fibres and cell membrane blebbing in
myotubes.
Conclusion: Our results confirm that NM associated α-actin mutations induce a range of defects
at the biochemical level as well as in cultured fibroblasts and muscle cells.
Background
Nemaline myopathy (NM) is a neuromuscular disorder,
characterized by muscle weakness and hypotonia. It is a
disease of the skeletal muscle sarcomere and is caused by
mutations in components of the thin filament [1]; in
about 20% of the cases this is in α-skeletal muscle actin
(ACTA1, further referred to as α-actin) [2-4]. At the cellu-
lar level typical patient phenotypes are the presence of
actin containing intranuclear or sarcoplasmic rod-shaped
structures (nemaline rods) that may be present either in
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the sarcoplasm or in the nuclei [4]. Another congenital
myopathy associated with ACTA1 mutations is actin
myopathy, this disease is phenotypically similar to NM,
and often studied together with NM, however the cellular
inclusions here are actin aggregates instead of rods [4].
Curiously, the proportion of muscle fibers containing
rods or aggregates does not correlate with the degree of
muscle weakness [5].
To date, more than 100 α-actin mutations leading to NM
or actin myopathy have been identified [6]. Given that α-
actin is an essential protein for muscle function it is not
surprising that mutations in this protein cause diseases
(reviewed in Tondeleire et al., in press, [7]). Actin mole-
cules require folding by the chaperones prefoldin and the
cytoplasmic chaperonin CCT, to become functionally
active [8-10] and have an absolute requirement for ATP to
remain stable [11]. Their self assembly results in the for-
mation of actin filaments that in muscle are part of the
thin filaments and that interact with the various actin
binding proteins such as α-actinin, tropomyosin and
myosin in muscle. As a result, a disease-causing mutation
in actin can affect one or more of these properties or func-
tions and this heterogeneity at the biochemical level can
cause mixed phenotypes and render diseases also hetero-
geneous at the cellular level. This was reflected in our pre-
vious reports on several congenital myopathy causing
mutants [12-14] and Rommelaere et al, submitted. We
discovered four different biochemical phenotypes [12]
and were able to induce typical disease characteristics as
rods and aggregates in fibroblasts, myoblasts and myo-
tubes [12,14]. Additionally, we found that NM associated
actin mutants induce cell membrane blebbing in differen-
tiating myoblasts (Rommelaere et al., submitted). Here
we biochemically analyze 12 new α-actin mutants associ-
ated with NM and investigate their cellular phenotypes as
well as further characterization of 8 mutants biochemi-
cally characterized in Costa et al. [12].
Methods
Construction and biochemical analysis of the α-actin CCD 
and CFTD causing mutants
Construction and biochemical analysis of the NM causing
α-actin mutants were performed as described previously
[12,14,15]. Briefly, mutants were expressed as 35S-labeled
proteins in in vitro transcription translation reactions in
reticulocyte lysates and analysed on native gels with or
without ATP, followed by autoradiography. For band-
shift assays thymosin β4, DNAseI and vitamin D binding
protein were added to the reaction. Co-polymerisation
assays were performed by adding WT rabbit skeletal mus-
cle α-actin. After polymerisation, the soluble and insolu-
ble fraction were separated by centrifugation, and the
amount of mutant actin in each fraction was analysed by
autoradiography.
Cell culture and transfection
Cell culture and transfection were performed as previ-
ously described [12,14]. Briefly, NIH3T3 fibroblasts were
transfected with lipofectamin 2000 (Invitrogen), accord-
ing to manufacturer's protocol. Coverslips were mounted
for immunofluorescence after 24 hours of transfection.
Sol 8 myogenic cells [16] were seeded in 12 well plates
containing thermanox coverslips (Nunc). After 24 hours
the cells were transfected using jetPEI (Qbiogene) or
nucleofected, using cell line nucleofector kit V (Amaxa
biosystems) with the pcDNA3.1 vectors encoding N-ter-
minally myc-tagged α-skeletal muscle actin (wild type or
mutant). Coverslips were mounted for immunofluores-
cence after 48 hours of transfection. To promote fusion
(F) of myoblasts into myotubes, the growth medium was
replaced by a differentiation medium with 2% horse
serum. Myotubes were immunostained on day F+4 or
F+5.
Immunological staining
Standard immunological staining was performed [12,14].
To visualise the mutant actins we used a polyclonal anti-
myc antibody (Abcam) and fluorescent phalloidin
(Molecular Probes) for filamentous actin. The immunola-
belled samples were examined using an Olympus IX71
epifluorescence microscope and images were acquired
using a cooled Spot Camera (Diagnostic Instruments) and
Analysis software (Soft Imaging Systems).
For statistics of stress fibre incorporation and diffuse cyto-
plasmic myc-actin staining, pictures were visually
inspected and blindly scored by two persons. P-values
were calculated by a Fisher's exact test http://
www.socr.ucla.edu/htmls/ana/
FishersExactTest_Analysis.html on the separate experi-
ments.
Results
Biochemical characterization of α-skeletal muscle actin 
mutants causing NM
In a previous study [12], we biochemically characterized a
set of actin mutants causing nemaline myopathy and dis-
covered four different biochemical phenotypes: folding
defective mutants, unstable mutants, mutants with
reduced copolymerisation capacity and mutants without
defects in these tests (for details and limitations of these
assays see [12,15,17]). In the present study, we investi-
gated twelve new NM mutants using similar approaches.
In patient muscles, these mutants induce different abnor-
mal structures such as intranuclear and cytoplasmic rods
and/or an excess of thin filaments (Table 1).
The locations of the mutations in the actin molecule are
displayed in pink on the 3D-representation of the actin
molecule (Figure 1A) [18]. Mutations are found in sub-BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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domains I (D25N and R116H), II (V35L, P38L, H73L and
I75L), III (V163M) and IV (Q246R, G251R, R256H and
M269R). Some of these residues (D25, H73, I75, R116
and V163) are in or near the nucleotide-binding pocket.
[19-21]
All these actin mutants are capable of folding properly,
since they migrate at a position similar to monomeric
actin in gels with ATP (Figure 1B) and since they can bind
to the ABPs tested (i.e. thymosin β4, DNAseI and VDBP,
Table 1). However, for three of the mutants act E83K,
R116H and V163M a significant proportion of the pro-
teins remains bound to CCT on native gels (Figure 1B),
indicating that they fold less well compared to WT-α-
actin. On gels without ATP, mutants act E83K, V163M and
M269R show a slight increase in CAP-binding [22]. This
effect is, however, not very strong and precludes to conclu-
sively decide that these mutants are unstable due to
impaired nucleotide binding [10,17]. We note however
that mutants E83K and V163M induced more aggregation
in the in vitro translation reaction than does mutant
R116H (Table 1). In copolymerisation tests mutants act
P38L, H73L, E83K, R116H, V163M, R256H and M269R
displayed reduced copolymerization capacity, whereas
mutants act D25N, V35L, I75L, Q246R and G251D show
normal copolymerisation.
Cellular phenotypes induced by the NEM causing α-
skeletal muscle actin mutants
Since we previously observed that expression of myc-
tagged α-actin mutants associated with NM can induce a
range of defects in the actin cytoskeleton, we constructed
all of these mutants with an N-terminal myc-tag and
transfected them in NIH3T3 fibroblasts and Sol8 myob-
lasts [12,14] and Rommelaere et al. submitted. In order to
analyse their incorporation in the actin cytoskeleton or
the occurrence of rods or aggregates, we performed immu-
nological staining of the myc-tagged mutants, together
with fluorescent phalloidin staining for F-actin containing
structures. We performed a similar analysis on myc-tagged
actin mutants N115S, G182D, R183G, R183C, Q263L
and G268C (green in Figure 1A), which were previously
biochemically characterized in Costa et al. (Table 2)
(additionally, G182D which was only characterized in
fibroblasts in Costa et al. was analysed here in muscle
cells) [12]. The results of this ex vivo analysis are summa-
rized in Table 3.
α-actin mutants induce nemaline rod-like structures and aggregates 
in fibroblasts and myoblasts
Four of the investigated α-actin mutants induce rod-like
structures in fibroblasts: I75L and V163M induce phalloi-
din positive intranuclear rods (Figure 2) and H73L
induces cytoplasmic phalloidin positive rods (Figure 2).
R116H induces perinuclear cytoplasmic phalloidin nega-
tive rods (Figure 2).
Upon expression of act V163M in myoblasts we also
observed intranuclear rods. Another mutation at this posi-
tion, V163L, similarly induces intranuclear rods in both
fibroblasts and myoblasts [12]. V163 lies close to the
nuclear export signal [23] and therefore this mutation
could interfere with nuclear export resulting in intranu-
clear rods (Figure 2). Domazetovska et al. expressed EGFP-
or untagged V163L and V163M actin in fibroblast and
myoblast cell lines and observed similar phalloidin posi-
tive rods. Our co-polymerization results support their
observation that intranuclear rods induced by V163M
Table 1: Description and results of the biochemical characterization of 16 new nemaline myopathy causing α-skeletal muscle actin 
mutants.
Mutant phenotype Folding CAP ABP copol In actin structure (Kabsch) reference
WT ++ + + +
D25N severe NEM  + + + ++ Subdomain I, Close to ATP cleft [4]
V35L severe NEM + + + ++ Subdomain II, Buried [19]
P38L severe NEM + + + + Subdomain II [19]
H73L severe NEM  + - +, VDBP+/- + Subdomain II, In ATP cleft, stabilizing interaction 
with D179
[19]
I75L severe NEM + + +, VDBP+/- ++ Subdomain II, In ATP cleft [19]
E83K Typical NEM +/- + + + more aggr Helix [19]
R116H Severe NEM  + +/- + + + more aggr Subdomain I, Helix, close to ATP cleft [4]
V163M IRM +/- + + + more aggr Subdomain III, Buried, near ATP-cleft [27]
Q246R mild, typical and severe + + + ++ Subdomain IV, Close to F-actin contact [19,20]
G251D severe NEM + +/- + ++ Subdomain IV, At surface [19]
R256H severe NEM + - + + Subdomain IV, Close to F-actin contact [2]
M269R mild NEM + + + + Subdomain IV, F-actin contact, hydrophobic plug [21]
The properties investigated here are folding, binding to cyclase associated protein (CAP), binding to the actin binding proteins (ABP) thymosinβ4, 
DNAseI and Vitamin D binding protein (VDBP) and copolymerisation with rabbit α-skeletal muscle actin (copol). Also the location in the actin 
structure according to Kabsch et al. [18] is indicated, in addition to the patients phenotype as presented in the reference with NEM = nemaline 
myopathy, sarcoplasmic nemaline bodies; IRM = intranuclear rod myopathy.BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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(A) Location of the studied ACTA1 mutations on the 3D-representation of the actin molecule [18] Figure 1
(A) Location of the studied ACTA1 mutations on the 3D-representation of the actin molecule [18]. Mutations 
indicated in green were biochemically analysed in this study, mutations indicated in pink were analysed in Costa et al. [12]. (B) 
Native gel analysis of twelve α-actin mutants causing NM. Autoradiograms of native gels of 35S-labeled WT α-actin and 12 
mutants causing NM run with or without ATP. Actins were produced in in vitro transcription translation reactions in reticulo-
cyte lysate, which endogenously contains CAP [22] and the actin folding machinery, prefoldin (PFD) and CCT [8,9,15]. The 
positions of these complexes with actin are indicated. The graph underneath indicates the percentage of actin in each of the 
bands (associated with CCT (purple), with prefoldin (white, (+ATP)) or CAP (white, (-ATP)) and free actin (red). In each lane 
the total actin is the sum of these three actin species.
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might be due to an increased availability of monomeric
actin caused by reduced incorporation of the mutant in
actin filaments [24,25]. However we can not generalize
this to the other mutants as I75L for instance displays nor-
mal co-polymerisation.
Another phenotype associated with expression of nema-
line myopathy associated actin mutants in cultured cells is
the formation of actin-containing phalloidin negative
aggregates. For eleven of the investigated mutants we
observed these in fibroblasts (D25N, E83K, R116H,
V163M, R183G, R183C, Q246R, G251D, G268C and
M269R) (Figure 3). In most cases the aggregates were cyto-
plasmic or perinuclear, yet for R116H and V163M we
additionally observed intranuclear aggregates, consistent
with the fact that these mutants also induce intranuclear
rods. Strikingly, E83K, R116H and V163M also aggregate
in the in vitro translation assays (see above). In addition,
for a subset of mutants, we also observed cytoplasmic
aggregates in Sol8 myoblasts. This is the case for mutants
D25N, P38L, I75L, M132V, V163M, R183C, G251D,
R256H and Q263L (Figure 3).
As in previous reports [12], not all mutants induced the
formation of rods or aggregates, and these phenotypes are
induced more in fibroblasts than in muscle cells. This sup-
ports the hypothesis that rods can be considered second-
ary effects in patient muscles, which serve as 'rescue'
mechanisms to remove the mutant actin from the active
pool, and that other defects could underlie the muscle
weakness in NM patients [26] (Rommelaere submitted).
The fact that we observed both phalloidin positive and
negative rod-like structures and aggregates, is consistent
with previous reports on fibroblasts and muscle cells
expressing NM causing actin mutants [13,27]. A lack of
phalloidin staining could indicate that the rods do not
contain filamentous actin, or that the F-actin is not acces-
sible for the phalloidin. At present it is not known
whether patient rods stain with phalloidin however our
results indicate that rods induced by different mutants
could have a different composition and/or organisation.
Diffuse cytoplasmic myc-staining in fibroblasts
To test the ability of the mutants to incorporate in fila-
mentous structures, we calculated the percentage of
fibroblasts in which a particular mutant is able to incorpo-
rate in stress fibres. In addition, we also scored for diffuse
cytoplasmic staining of the myc-tagged mutant, which
gives a second indication of the (lack of) incorporation in
filamentous structures. Cells were visually inspected and
blindly scored for both parameters by two persons and the
mean was calculated. Similar to WT, all mutants are able
to incorporate in stress fibres in a certain percentage of the
cells. For G182D and I375L actin expressing fibroblasts
this was significantly lower than for WT actin expressing
cells (Figure 4A). The percentage of cells with a diffuse
cytoplasmic myc-staining, shows more variation (Figure
4B): V35L, P38L, H73L, and R183G induce this cytoplas-
mic staining in significantly more cells than WT myc-
actin. N115S, V163M, G182D, Q246R, G251D, R256H,
M269R and I375L also have a tendency to display this
phenotype more than cells expressing WT myc-actin, yet
they do so to a lesser extent than the former mutants.
Five mutants induce cell blebbing in muscle cells
Consistent with our previous observation that particular
NM actin mutants induce blebbing in myoblasts (Rom-
melaere et al., submitted), we also found five mutants
here displaying this phenotype: act P38L, E83K, R116H,
R183C and Q246R (Figure 4C–F). Each of these mutants
is enriched in the blebs.
Phenotypes induced in myotubes
We differentiated myoblasts, transfected with the α-actin
mutants, during five days and allowed them to form
multinucleated myotubes. Immunological staining
revealed that all studied mutants incorporate to a certain
degree in actin fibers in myotubes (shown for H73L and
G268C in Figure 5).
Table 2: clinical phenotype and position or the function in the actin structure of mutations which were biochemically characterized in 
Costa et al. 2004 [12].
Mutation Phenotype Position or Function in Actin Structure
N115S typical, NEM Buried, near nucleotide cleft
M132V mild, NEM Buried
G182D typical, NEM in nucleotide cleft
R183C severe, NEM H-bonds for nucleotide cleft closure
R183G typical./severe, NEM H-bonds for nucleotide cleft closure
Q263L severe, NEM Surface, near hydrophobic plug
G268C mild/typical. NEM F-actin contact, hydrophobic pocket
I357L Severe, NEM, IRM buried
NEM = nemaline myopathy, sarcoplasmic nemaline bodies; IRM = intranuclear rod myopathy.BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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Table 3: Summary of the phenotypes observed upon expression of NM associated α-actin mutants in cell cultures.
Mutant Clinical phenotype Cell line aggreg Rods Fibers/
Cables
Diffuse cyto local Blebs or membrane 
protrusions
WT -f i b r o b l a s t X
myoblast X
myotube X
D25N Severe NEM  fibroblast X X +/-
myoblast X X
myotube X X
V35L Severe NEM fibroblast X X
myoblast X X
myotube X X
P38L Severe NEM fibroblast X X
myoblast X X X
myotube X
H73L Severe NEM  fibroblast Cyto X X
myoblast X
myotube X
I75L Severe NEM fibroblast IR X
myoblast X X
myotube X X
E83K Typical NEM fibroblast X X
myoblast Few X X
myotube X
N115S Typical NEM fibroblast X +/-
myoblast X
myotube X
R116H Severe NEM  fibroblast X Cyto, perinuclear X
myoblast Few X X
myotube X X
M132V mild NEM fibroblast X
myoblast X X
myotube X
V163M IRM fibroblast X IR + cyto Low incorporation +/-
myoblast X IR Few X
myotube Thick fibers
G182D typical NEM fibroblast Low incorporation +/-
myoblast X X
myotube X
R183C Severe NEM  Fibroblast IR X X
Myoblast X X X
Myotube X
R183G Int + Severe NEM  Fibroblast X X X
Myoblast X
Myotube XBMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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Act R116H, M132V, V163M transfected myotubes show
an aberrant phenotype at this differentiation stage (Figure
5). In myotubes expressing act V163M, actin fibers appear
thickened, a phenotype we, and others, previously also
observed for act V163L (Rommelaere et al., submitted,
[13]). This cellular phenotype is also consistent with the
sarcomeric disorganization in Drosophila muscles express-
ing V163M [25]. Act R116H and M132V expressing myo-
tubes display blebs or membranous protrusions as
described for other NM mutants by Rommelaere et al.
(Figure 5).
Conclusion
We corroborate that NM associated α-actin mutations can
induce a range of defects, both at the biochemical and cel-
lular level. We show that the twenty NM mutants investi-
gated here score at least one of the previously described
cellular NM or actin myopathy associated phenotypes
(Table 3), i.e. the cells display intranuclear or cytoplasmic
rods, aggregates, blebs (only in differentiating myoblasts),
diffuse cytoplasmic myc-actin staining or thickened actin
fibres in myotubes. As observed before, not a single
mutant can reproduce all phenotypes although some
mutants display multiple, occasionally cell line depend-
ent, phenotypes. On the other hand, not all mutants
induce rod-like structures or aggregates, hallmarks in
patient muscles, which supports the fact that rods could
be secondary effects, and that other mutant induced
defects are underlying the muscle weakness in NM
patients. Phalloidin staining of cells also indicate that
nemaline rods induced by different actin mutants can
have different organisation or composition. Additionally,
as concluded before in Costa et al., [12] there is no corre-
lation between the observed biochemical and cellular
phenotypes nor between one of these and the clinical sit-
uation.
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Q246R Mild,
typical and severe NEM
Fibroblast X X
Myoblast X X
Myotube X
G251D Severe NEM Fibroblast X X +/-
Myoblast X X X
Myotube X
R256H Severe NEM Fibroblast X +/-
Myoblast X X
Myotube X
Q263L Severe NEM fibroblast X
myoblast X X
myotube X
G268C Mild/typical NEM fibroblast X X +/-
myoblast X X
myotube X
M269R Mild NEM fibroblast X X +/-
myoblast X
myotube X X
I357L IRM fibroblast Low  incorporation +/-
myoblast X
myotube X
NEM nemaline myopathy, IRM: Intranuclear Rod Myopathy, IR intranuclear rods, cyto: cytoplasmic, a cross indicates that the phenotype or normal 
property (fibers/cables) is present, Int: intermediate  lethal phenotype
Table 3: Summary of the phenotypes observed upon expression of NM associated α-actin mutants in cell cultures. (Continued)BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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α-actin mutants induce rods in cell line cultures Figure 2
α-actin mutants induce rods in cell line cultures. (A) Myc-actin (red) and phalloidin (green) staining of NIH3T3 fibrob-
lasts and (B) myc-actin staining of Sol8 myoblasts expressing WT actin or the indicated NM associated α-actin mutant. Scale 
bars are 20 μm.BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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α-actin mutants induce aggregates in cell line cultures Figure 3
α-actin mutants induce aggregates in cell line cultures. (A) Myc-actin (red) and phalloidin (green) staining of NIH3T3 
fibroblasts and (B) myc-actin staining of Sol8 myoblasts expressing WT actin or the indicated NM associated α-actin mutant. 
Scale bars are 20 μm.BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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Some α-actin mutants induce a diffuse cytoplasmic myc-staining, five α-actin mutants induce blebbing Figure 4
Some α-actin mutants induce a diffuse cytoplasmic myc-staining, five α-actin mutants induce blebbing. (A-B) 
graphs indicating the mean percentage of fibroblasts where myc α-actin is incorporated into stress fibres (A) or with diffuse 
cytoplasmic myc-actin staining (B). Error bars show the standard error of the mean. (* p < 0,05 for both measurements, or one 
measurement if p < 0,07 for the second measurement) (C-G) Myc-actin staining of Sol8 myoblasts expressing α-actin mutants 
that induce cell membrane blebbing.BMC Research Notes 2009, 2:40 http://www.biomedcentral.com/1756-0500/2/40
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